REGN Regeneron Pharmaceuticals, Inc. - Common Stock
$840.42
价格 · 八月 19, 2026
截至...的财报数据 七月 30, 2026
52周区间
$541–$843
99% of range
分析师评级
BUY
37 analysts
目标价
$840
+0% upside
P/E (TTM)
20.3
ROE
14.7%
净利润率
31.4%
关于 Regeneron Pharmaceuticals, Inc. - Common Stock 公司概况（来自维基百科）
再生元製藥 是一家美国制药公司。是全球为数不多不被大型药企收购、保持独立运营的头部生物科技公司。
阅读更多
再生元製藥（英語：Regeneron Pharmaceuticals, Inc.） 是一家美国制药公司。是全球为数不多不被大型药企收购、保持独立运营的头部生物科技公司。
历史
成立于1988年。最初主要研究神经营养因子及其再生能力，后来也开始研究细胞因子等其他领域。
产品
其正在开发的商业化药物和候选产品旨在帮助患有眼疾、过敏性和炎症性疾病、癌症、心血管和代谢性疾病、疼痛、传染病和罕见疾病的患者。产品包括眼科药物阿柏西普、预防痛风急性发作的rilonacept。它和赛诺菲合作开发有降脂药阿利西尤單抗、治疗哮喘及異位性皮膚炎的dupixent/dupilumab、抗炎药sarilumab以及治疗晚期皮肤鳞状细胞癌的cemiplimab。
来源：维基百科, CC BY-SA 4.0 · 在维基百科上查看 ↗
REGN 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$840.42
市值
$115.89B
P/E (TTM)
20.3
每股收益 (TTM)
$41.48
营收 (TTM)
$14.34B
股息收益率
0.32%
ROE
14.7%
负债/权益
0.1
52周区间
$541 – $843
REGN 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$14.34B
2016-12-31
→
2025-12-31
EPS
$41.48
2016-12-31
→
2025-12-31
自由现金流
$4.08B
2016-12-31
→
2025-12-31
利润率
31.4%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
REGN
同行中位数
P/E (TTM)
20.3
17.7
P/S (TTM) (市销率 (TTM))
8.1
6.8
P/B (市净率)
3.7
6.4
EV / EBITDA (企业价值 / EBITDA)
26.5
—
Price / FCF (股价/自由现金流)
28.4
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
REGN
同行中位数
Operating Margin (营业利润率)
24.9%
—
Net Profit Margin (净利润率)
31.4%
20.3%
ROA
11.5%
11.4%
ROE
14.7%
16.8%
ROIC
9.3%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
REGN
同行中位数
Debt / Equity (负债/股东权益比率)
0.1
—
Current Ratio (流动比率)
4.1
3.4
Quick Ratio (速动比率)
3.3
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
REGN
同行中位数
Revenue YoY (营收同比增长)
0.99%
—
Revenue CAGR 3Y (营收3年复合年增长率)
5.6%
—
Revenue CAGR 5Y (营收5年复合年增长率)
11.0%
—
EPS YoY
8.2%
—
Net Income YoY (净利润同比增长)
2.1%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
REGN
同行中位数
Payout Ratio (派息率)
8.2%
—
股息 收益率、派息率、股息历史、5年CAGR
股息收益率
0.32%
派息率
8.2%
5年股息复合年增长率 (CAGR)
—
| 除息日 | 金额 |
|---|---|
| 2026年8月18日 | $0.9400 |
| 2026年5月20日 | $0.9400 |
| 2026年2月20日 | $0.9400 |
| 2025年11月20日 | $0.8800 |
| 2025年8月18日 | $0.8800 |
| 2025年5月20日 | $0.8800 |
| 2025年2月20日 | $0.8800 |
REGN 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
37 位分析师
- 强烈买入 8 21.6%
- 买入 18 48.6%
- 持有 11 29.7%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
27 位分析师 · 2026-08-19
中位数
$824.00
现在
$840.42
最低
$730.00
最高
$1030.00
中位数目标
$824.00
-2.0%
平均目标
$840.43
+0.0%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
1.7%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $14.29 | $10.47 | 3.8% |
| 2026年3月31日 | $9.47 | $9.12 | 0.35% |
| 2025年12月31日 | $11.44 | $10.83 | 0.61% |
| 2025年9月30日 | $11.83 | $9.78 | 2.0% |
| 2025年6月30日 | $12.89 | $8.61 | 4.3% |
| 2025年3月31日 | $8.22 | $9.00 | -0.78% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | — |
| ABBV | — | 96.8 | 8.6% | 6.9% | 15367.3% | — |
| AMGN | $176.35B | 23.0 | 10.0% | 21.0% | 95.9% | — |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | — |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | — |
| RVMD | — | — | — | — | — | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B | $8.50B | $6.56B | $5.15B | $5.87B | $4.86B | $4.10B | $2.82B | |
| Cost of Revenue | · | · | · | · | · | · | $403M | $238M | $203M | $195M | $242M | $129M | |
| R&D Expense | $5.85B | $5.13B | $4.44B | $3.59B | $2.86B | $2.65B | $2.45B | $1.47B | $2.08B | $2.05B | $1.62B | $1.27B | |
| SG&A Expense | $2.70B | $2.95B | $2.63B | $2.12B | $1.82B | $1.35B | $1.34B | $1.13B | $1.32B | $1.18B | $839M | $519M | |
| Operating Expenses | $10.77B | $10.21B | $9.07B | $7.43B | $7.12B | $4.92B | $4.35B | $2.61B | $3.79B | $3.53B | $2.85B | $2.00B | |
| Operating Income | $3.58B | $3.99B | $4.05B | $4.74B | $8.95B | $3.58B | $2.21B | $2.53B | $2.08B | $1.33B | $1.25B | $824M | |
| Interest Expense | · | · | $73M | $59M | $57M | $57M | $30M | $28M | $25M | $7M | $14M | $37M | |
| Other Non-op | $1.70B | $844M | $225M | $179M | $436M | $291M | $250M | $47M | $24M | $6M | $-13M | $-25M | |
| Pretax Income | $5.23B | $4.78B | $4.20B | $4.86B | $9.33B | $3.81B | $2.43B | $2.55B | $2.08B | $1.33B | $1.23B | $761M | |
| Income Tax | $726M | $367M | $246M | $520M | $1.25B | $297M | $313M | $109M | $880M | $434M | $589M | $423M | |
| Net Income | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B | $3.51B | $2.12B | $2.44B | $1.20B | $896M | $636M | $338M | |
| EPS (Basic) | $43.07 | $40.90 | $37.05 | $40.51 | $76.40 | $32.65 | $19.38 | $22.65 | $11.27 | $8.55 | $6.17 | $3.36 | |
| EPS (Diluted) | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 | $30.52 | $18.46 | $21.29 | $10.34 | $7.70 | $5.52 | $2.98 | |
| Shares (Basic) | 104,600,000 | 107,900,000 | 106,700,000 | 107,100,000 | 105,700,000 | 107,600,000 | 109,200,000 | 107,900,000 | 106,300,000 | 104,700,000 | 103,061,000 | 100,612,000 | |
| Shares (Diluted) | 108,600,000 | 115,100,000 | 113,700,000 | 113,500,000 | 112,200,000 | 115,100,000 | 114,600,000 | 114,800,000 | 115,900,000 | 116,300,000 | 115,230,000 | 113,413,000 | |
| EBITDA | $4.12B | $4.47B | $4.47B | $5.08B | $9.23B | $3.81B | $2.42B | $2.68B | $2.23B | $1.44B | $1.33B | $891M |
资产负债表 27
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.12B | $2.49B | $2.73B | $3.11B | $2.89B | $2.19B | $1.62B | $1.47B | $813M | $535M | $809M | $649M | |
| Short-term Investments | $5.49B | $6.52B | $8.11B | $4.64B | $2.81B | $1.39B | $1.60B | $1.34B | $597M | $503M | $236M | $252M | |
| Receivables | $5.74B | $6.21B | $5.67B | $5.33B | $6.04B | $4.11B | $2.10B | $1.72B | $1.54B | $1.34B | $1.15B | $739M | |
| Inventory | $3.20B | $3.09B | $2.58B | $2.40B | $1.95B | $1.92B | $1.42B | $1.15B | $726M | $399M | $239M | $129M | |
| Prepaid Expense | $475M | $349M | $387M | $411M | $332M | $161M | $274M | $243M | $225M | $131M | $164M | $79M | |
| Current Assets | $18.02B | $18.66B | $19.48B | $15.88B | $14.01B | $9.78B | $7.69B | $6.45B | $4.33B | $3.18B | $2.92B | $2.08B | |
| PP&E (Net) | · | · | · | · | $3.48B | $3.22B | $2.89B | $2.58B | $2.36B | $2.08B | $1.59B | $974M | |
| PP&E (Gross) | · | · | · | · | · | · | $3.81B | $3.30B | $2.92B | $2.51B | $1.93B | $1.23B | |
| Accum. Depreciation | · | · | · | · | · | · | $922M | $729M | $566M | $426M | $331M | $254M | |
| Intangibles | $1.26B | $1.15B | $1.04B | $916M | $7M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.82B | $1.14B | $444M | $336M | $216M | $168M | $145M | $127M | $78M | $20M | $6M | $3M | |
| Total Assets | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B | $17.16B | $14.81B | $11.73B | $8.76B | $6.97B | $5.61B | $3.84B | |
| Accounts Payable | $939M | $790M | $607M | $589M | $564M | $476M | $418M | $218M | $178M | $879M | $644M | $483M | |
| Short-term Debt | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Current Liabilities | $4.37B | $3.94B | $3.42B | $3.14B | $3.93B | $2.70B | $2.10B | $1.44B | $1.14B | $1.24B | $811M | $655M | |
| Capital Leases | $229M | $204M | $69M | $56M | · | · | · | $708M | · | · | · | · | |
| Other Non-current Liabilities | $2.02B | $1.57B | $854M | $638M | $680M | $687M | $318M | $362M | $152M | $100M | $116M | $40M | |
| Total Liabilities | $9.30B | $8.41B | $7.11B | $6.55B | $6.67B | $6.14B | $3.72B | $2.98B | $2.62B | $2.52B | $1.95B | $1.29B | |
| Total Debt | $1.99B | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | · | · | · | · | · | · | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $108.0K | $106.0K | $102.0K | |
| Paid-in Capital | $13.99B | $12.86B | $11.35B | $9.95B | $8.09B | $6.72B | $4.43B | $3.91B | $3.51B | $3.03B | $3.10B | $2.45B | |
| Retained Earnings | $35.80B | $31.67B | $27.26B | $23.31B | $18.97B | $10.89B | $7.38B | $5.25B | $2.95B | $1.75B | $853M | $217M | |
| Treasury Stock | $18.61B | $15.17B | $12.56B | $10.35B | $8.26B | $6.61B | $740M | $396M | $316M | $316M | $306M | $170M | |
| AOCI | $78M | $-8M | $-81M | $-239M | $-26M | $29M | $21M | $-12M | $600.0K | $-13M | $9M | $52M | |
| Stockholders' Equity | $31.26B | $29.35B | $25.97B | $22.66B | $18.77B | $11.03B | $11.09B | $8.76B | $6.14B | $4.45B | $3.65B | $2.55B | |
| Liabilities + Equity | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B | $17.16B | $14.81B | $11.73B | $8.76B | $6.97B | $5.61B | $3.84B | |
| Shares Outstanding | 137,600,000 | 136,000,000 | 133,100,000 | 130,400,000 | 126,200,000 | 121,500,000 | 113,300,000 | · | · | · | · | · |
现金流 19
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $544M | $483M | $421M | $341M | $286M | $236M | $210M | $148M | $146M | $105M | $75M | $53M | |
| Stock-based Comp | $994M | $983M | $885M | $725M | $602M | $432M | $464M | $427M | $507M | $560M | $459M | $322M | |
| Deferred Tax | $-785M | $-757M | $-838M | $-746M | $-147M | $76M | $-131M | $-140M | $319M | $-360M | $-130M | $-46M | |
| Amort. of Intangibles | $179M | $129M | $92M | $38M | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | $-278M | $-700M | $172M | $356M | $-1.73B | $-1.64B | $-230M | $-685M | $-863M | $273M | $291M | $86M | |
| Operating Cash Flow | $4.98B | $4.42B | $4.59B | $5.01B | $7.08B | $2.62B | $2.43B | $2.20B | $1.31B | $1.49B | $1.33B | $752M | |
| CapEx | $898M | $756M | $719M | $590M | $552M | $615M | $430M | $383M | $273M | $512M | $678M | $333M | |
| Investing Cash Flow | $-629M | $-2.47B | $-3.19B | $-3.78B | $-5.38B | $-71M | $-2.03B | $-1.46B | $-1.01B | $-1.05B | $-908M | $-421M | |
| Debt Issued | · | · | · | $0 | $0 | $1.98B | $0 | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $1.98B | · | · | · | · | · | · | |
| Stock Issued | $636M | $1.47B | $1.15B | $1.52B | $1.67B | $2.58B | $212M | $114M | $240M | $127M | $206M | $126M | |
| Stock Repurchased | $3.44B | $2.60B | $2.23B | $2.08B | $1.65B | $5.85B | $276M | $4M | $0 | $0 | · | · | |
| Net Stock Activity | $-2.80B | $-1.14B | $-1.09B | $-563M | $27M | $-3.27B | $-64M | $110M | $240M | $127M | $206M | $126M | |
| Dividends Paid | $370M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-3.72B | $-2.20B | $-1.79B | $-1.01B | $-1.01B | $-1.97B | $-252M | $-77M | $-24M | $-700M | $-263M | $-219M | |
| Net Change in Cash | $635M | $-249M | $-382M | $221M | $691M | $577M | $150M | $655M | $278M | $-261M | $160M | $113M | |
| Taxes Paid | $1.25B | $743M | $870M | $1.50B | $1.22B | $188M | $342M | $206M | $755M | $481M | $276M | $60M | |
| Free Cash Flow | $4.08B | $3.66B | $3.88B | $4.42B | $6.53B | $2.00B | $2.00B | $1.81B | $1.03B | $961M | $653M | $410M | |
| Levered FCF | · | · | $3.81B | $4.37B | $6.48B | $1.95B | $1.97B | $1.79B | · | · | $645M | $393M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 24.9% | 28.1% | 30.9% | 38.9% | 55.7% | 42.1% | 28.1% | 37.8% | 35.4% | 27.4% | 30.5% | 29.7% | |
| Net Margin | 31.4% | 31.1% | 30.1% | 35.6% | 50.2% | 41.3% | 26.9% | 36.4% | 20.4% | 18.4% | 15.5% | 12.3% | |
| Pretax Margin | 36.5% | 33.7% | 32.0% | 39.9% | 58.0% | 44.8% | 30.9% | 38.0% | 35.4% | 27.4% | 29.8% | 27.5% | |
| EBITDA Margin | 28.7% | 31.5% | 34.1% | 41.7% | 57.5% | 44.9% | 30.8% | 40.0% | 37.9% | 29.5% | 32.3% | 31.6% | |
| ROA | 11.5% | 12.5% | 12.7% | 15.9% | 37.9% | 22.0% | 15.9% | 23.8% | 15.2% | 14.2% | 13.5% | 10.2% | |
| ROE | 14.7% | 15.0% | 15.5% | 19.7% | 44.8% | 33.2% | 19.6% | 29.4% | 22.6% | 22.1% | 20.5% | 15.4% | |
| ROIC | 9.3% | 11.8% | 13.6% | 17.2% | 37.3% | 25.4% | 17.4% | 27.7% | 19.5% | 20.1% | 17.8% | 14.8% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 4.7 | 5.7 | 5.1 | 3.6 | 3.6 | 3.7 | 4.5 | 3.8 | 2.6 | 3.6 | 3.3 | |
| Quick Ratio | 3.3 | 3.9 | 4.8 | 4.2 | 3.0 | 2.5 | 2.5 | 3.1 | 2.6 | 1.9 | 2.7 | 2.5 | |
| Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | · | · | · | |
| Interest Coverage | · | · | 55.4 | 79.8 | 156.1 | 62.9 | 73.2 | 89.9 | · | · | 87.9 | 22.4 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.8 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 0.4 | 0.6 | 1.3 | 1.3 | |
| Receivables Turnover | 2.4 | 2.4 | 2.4 | 2.1 | 3.2 | 3.3 | 4.1 | 4.1 | 4.1 | 3.9 | 4.3 | 3.7 |
增长率 9
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.99% | 8.3% | 7.8% | -24.3% | 89.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.6% | -4.0% | 15.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 8.2% | 10.3% | -9.0% | -46.9% | 135.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 2.8% | -18.9% | 4.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 6.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | 11.6% | -8.9% | -46.3% | 129.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.3% | -18.2% | 4.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B | $8.50B | $6.56B | $5.15B | $5.87B | $4.86B | $4.10B | $2.82B | |
| Net Income TTM | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B | $3.51B | $2.12B | $2.44B | $1.20B | $896M | $636M | $338M | |
| Market Cap | $106.21B | $96.88B | $116.90B | $94.08B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $99.59B | $89.85B | $108.04B | $88.32B | · | · | · | · | · | · | · | · | |
| P/E | 18.6 | 18.6 | 25.3 | 18.9 | 8.8 | 15.8 | 20.3 | 17.5 | 36.4 | 47.7 | 98.3 | 137.7 | |
| P/S | 7.4 | 6.8 | 8.9 | 7.7 | · | · | · | · | · | · | · | · | |
| P/B | 3.4 | 3.3 | 4.5 | 4.2 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 3.5 | 3.4 | 4.7 | 4.3 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 21.3 | 21.9 | 25.4 | 18.8 | · | · | · | · | · | · | · | · | |
| P / FCF | 26.0 | 26.4 | 30.2 | 21.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 24.2 | 20.1 | 24.2 | 17.4 | · | · | · | · | · | · | · | · | |
| EV / FCF | 24.4 | 24.5 | 27.9 | 20.0 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 6.9 | 6.3 | 8.2 | 7.3 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.35% | 0.00% | 0.00% | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 5.4% | 5.4% | 4.0% | 5.3% | 11.4% | 6.3% | 4.9% | 5.7% | 2.8% | 2.1% | 1.0% | 0.73% | |
| Payout Ratio | 8.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Annual Payout | $370M | $0 | $0 | · | · | · | · | · | · | · | · | · |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.29B | $3.61B | $3.88B | $3.75B | $3.68B | $3.03B | $3.79B | $3.72B | $3.55B | $3.15B | $3.43B | $3.36B | $3.16B | $3.16B | $3.41B | $2.94B | |
| R&D Expense | $1.63B | $1.54B | $1.63B | $1.48B | $1.42B | $1.33B | $1.41B | $1.27B | $1.20B | $1.25B | $1.18B | $1.08B | $1.09B | $1.10B | $1.04B | $911M | |
| SG&A Expense | $662M | $648M | $775M | $658M | $634M | $633M | $792M | $714M | $759M | $689M | $738M | $640M | $652M | $601M | $660M | $529M | |
| Operating Expenses | $3.00B | $2.96B | $3.00B | $2.73B | $2.60B | $2.44B | $2.80B | $2.54B | $2.48B | $2.39B | $2.46B | $2.25B | $2.14B | $2.22B | $2.27B | $1.71B | |
| Operating Income | $1.29B | $643M | $880M | $1.03B | $1.08B | $592M | $990M | $1.18B | $1.07B | $751M | $973M | $1.11B | $1.02B | $947M | $1.15B | $1.22B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $16M | · | $18M | $19M | $18M | · | $15M | |
| Other Non-op | $245M | $201M | $176M | $756M | $443M | $322M | $-22M | $327M | $573M | $-35M | $193M | $18M | $85M | $-71M | $195M | $301M | |
| Pretax Income | $1.53B | $831M | $1.04B | $1.76B | $1.52B | $905M | $958M | $1.49B | $1.63B | $701M | $1.15B | $1.11B | $1.08B | $858M | $1.32B | $1.51B | |
| Income Tax | $231M | $104M | $199M | $303M | $127M | $96M | $40M | $152M | $196M | $-21M | $-12M | $103M | $114M | $40M | $128M | $194M | |
| Net Income | $1.30B | $727M | $845M | $1.46B | $1.39B | $809M | $918M | $1.34B | $1.43B | $722M | $1.16B | $1.01B | $968M | $818M | $1.20B | $1.32B | |
| EPS (Basic) | $12.62 | $6.99 | $8.16 | $14.09 | $13.24 | $7.58 | $8.55 | $12.40 | $13.25 | $6.70 | $10.88 | $9.48 | $9.05 | $7.64 | $11.18 | $12.31 | |
| EPS (Diluted) | $12.23 | $6.75 | $7.78 | $13.62 | $12.81 | $7.27 | $8.12 | $11.54 | $12.41 | $6.27 | $10.21 | $8.89 | $8.50 | $7.17 | $10.48 | $11.66 | |
| Shares (Basic) | 102,800,000 | 104,000,000 | -210,800,000 | 103,600,000 | 105,100,000 | 106,700,000 | -216,100,000 | 108,100,000 | 108,100,000 | 107,800,000 | -213,700,000 | 106,300,000 | 107,000,000 | 107,100,000 | -214,500,000 | 106,900,000 | |
| Shares (Diluted) | 106,000,000 | 107,700,000 | -218,400,000 | 107,200,000 | 108,600,000 | 111,200,000 | -231,600,000 | 116,200,000 | 115,400,000 | 115,100,000 | -227,600,000 | 113,400,000 | 113,900,000 | 114,000,000 | -226,400,000 | 112,800,000 | |
| EBITDA | $1.29B | $766M | · | $1.03B | $1.08B | $719M | · | $1.18B | $1.07B | $866M | · | $1.11B | $1.02B | $1.05B | · | $1.22B |
资产负债表 24
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.46B | $2.96B | $3.12B | $2.51B | $2.00B | $3.09B | $2.49B | $2.01B | $1.92B | $2.60B | $2.73B | $2.15B | $1.94B | $3.92B | $3.11B | $3.49B | |
| Short-term Investments | $5.54B | $5.79B | $5.49B | $5.94B | $5.47B | $5.26B | $6.52B | $7.78B | $7.89B | $7.92B | · | $7.76B | $6.99B | $5.04B | · | $3.53B | |
| Receivables | $6.57B | $5.73B | $5.74B | $5.69B | $5.61B | $5.56B | $6.21B | $6.11B | $5.72B | $5.22B | · | $5.58B | $5.12B | $5.12B | · | $5.55B | |
| Inventory | $3.08B | $3.10B | $3.20B | $3.25B | $3.21B | $3.19B | $3.09B | $3.02B | $2.87B | $2.71B | · | $2.56B | $2.51B | $2.42B | · | $2.41B | |
| Prepaid Expense | $802M | $621M | $475M | $596M | $574M | $469M | $349M | $412M | $682M | $415M | · | $575M | $366M | $406M | · | $446M | |
| Current Assets | $18.45B | $18.21B | $18.02B | $17.98B | $16.86B | $17.57B | $18.66B | $19.33B | $19.08B | $18.87B | · | $18.63B | $16.92B | $16.91B | · | $15.43B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.70B | |
| Intangibles | $1.31B | $1.29B | $1.26B | $1.38B | $1.35B | $1.17B | $1.15B | $1.12B | $1.10B | $1.06B | · | $1.02B | $953M | $929M | · | $804M | |
| Other Non-current Assets | $2.31B | $2.13B | $1.82B | $1.67B | $1.54B | $1.39B | $1.14B | $1.04B | $994M | $470M | · | $410M | $393M | $350M | · | $320M | |
| Total Assets | $41.73B | $40.87B | $40.56B | $40.17B | $38.22B | $37.55B | $37.76B | $37.44B | $36.09B | $34.37B | · | $32.16B | $30.66B | $30.06B | · | $27.68B | |
| Accounts Payable | $1.16B | $1.03B | $939M | $904M | $724M | $706M | $790M | $497M | $562M | $671M | · | $537M | $547M | $600M | · | · | |
| Current Liabilities | $5.53B | $5.11B | $4.37B | $4.43B | $3.67B | $3.57B | $3.94B | $3.66B | $3.51B | $3.58B | · | $3.60B | $3.10B | $3.10B | · | $2.88B | |
| Capital Leases | · | · | $229M | · | · | · | $204M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.28B | $2.13B | $2.02B | $1.86B | $1.70B | $1.67B | $1.57B | $1.54B | $1.46B | $908M | · | $832M | $717M | $677M | · | $599M | |
| Total Liabilities | $10.02B | $9.45B | $9.30B | $9.21B | $8.28B | $8.16B | $8.41B | $8.12B | $7.88B | $7.38B | · | $7.26B | $6.64B | $6.56B | · | $6.24B | |
| Total Debt | $1.99B | $1.99B | · | $1.99B | $1.99B | $1.98B | · | $1.98B | $1.98B | $1.98B | · | $1.98B | $1.98B | $1.98B | · | $1.98B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $14.70B | $14.40B | $13.99B | $13.79B | $13.49B | $13.19B | $12.86B | $12.70B | $12.32B | $11.94B | · | $11.25B | $10.89B | $10.60B | · | $9.52B | |
| Retained Earnings | $37.62B | $36.42B | $35.80B | $35.05B | $33.68B | $32.38B | $31.67B | $30.76B | $29.41B | $27.98B | · | $26.10B | $25.09B | $24.12B | · | $22.11B | |
| Treasury Stock | $20.57B | $19.41B | $18.61B | $17.94B | $17.28B | $16.22B | $15.17B | $14.19B | $13.46B | $12.86B | · | $12.27B | $11.77B | $11.05B | · | $9.91B | |
| AOCI | $-36M | $12M | $78M | $69M | $52M | $29M | $-8M | $60M | $-70M | $-77M | · | $-177M | $-198M | $-182M | · | $-275M | |
| Stockholders' Equity | $31.71B | $31.42B | $31.26B | $30.96B | $29.94B | $29.39B | $29.35B | $29.33B | $28.21B | $26.99B | $25.97B | $24.90B | $24.02B | $23.50B | $22.66B | $21.44B | |
| Liabilities + Equity | $41.73B | $40.87B | $40.56B | $40.17B | $38.22B | $37.55B | $37.76B | $37.44B | $36.09B | $34.37B | · | $32.16B | $30.66B | $30.06B | · | $27.68B | |
| Shares Outstanding | 138,000,000 | 137,900,000 | 137,600,000 | 136,200,000 | 136,200,000 | 136,100,000 | 136,000,000 | 135,300,000 | 134,800,000 | 134,200,000 | 133,100,000 | 132,100,000 | 131,600,000 | 131,400,000 | 130,400,000 | 129,000,000 |
现金流 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $124M | $123M | $145M | $137M | $135M | $127M | $126M | $122M | $121M | $114M | $113M | $105M | $103M | $100M | $100M | $93M | |
| Stock-based Comp | $243M | $257M | $249M | $237M | $252M | $256M | $304M | $225M | $223M | $230M | $240M | $204M | $202M | $239M | $232M | $166M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | $16M | |
| Other Non-cash | · | $-29M | · | · | · | $-146M | · | · | · | $446M | · | · | · | $212M | · | · | |
| Operating Cash Flow | $813M | $1.08B | $1.17B | $1.62B | $1.14B | $1.05B | $1.26B | $1.29B | $354M | $1.51B | $1.09B | $1.11B | $1.02B | $1.37B | $1.72B | $629M | |
| CapEx | $240M | $231M | $249M | $201M | $219M | $229M | $200M | $242M | $180M | $134M | $251M | $176M | $113M | $178M | $152M | $142M | |
| Investing Cash Flow | $-93M | $-429M | $220M | $-403M | $-1.09B | $648M | $351M | $-574M | $-557M | $-1.69B | $-66M | $-496M | $-2.39B | $-236M | $-1.86B | $192M | |
| Stock Issued | $49M | $163M | $504M | $40M | $32M | $61M | $91M | $255M | $438M | $682M | $301M | $269M | $91M | $485M | $373M | $318M | |
| Stock Repurchased | $1.17B | $794M | $672M | $664M | $1.06B | $1.04B | $973M | $735M | $604M | $291M | $289M | $546M | $689M | $711M | $431M | $935M | |
| Net Stock Activity | · | $-631M | · | · | · | $-981M | · | · | · | $391M | · | · | · | $-226M | · | · | |
| Dividends Paid | $97M | $98M | $93M | $91M | $93M | $94M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-1.22B | $-802M | $-780M | $-718M | $-1.13B | $-1.09B | $-1.14B | $-634M | $-478M | $47M | $-446M | $-407M | $-614M | $-322M | $-248M | $-725M | |
| Net Change in Cash | $-505M | $-153M | $611M | $498M | $-1.08B | $604M | $477M | $84M | $-682M | $-128M | $578M | $210M | $-1.98B | $809M | $-385M | $96M | |
| Free Cash Flow | · | $848M | · | · | · | $816M | · | · | · | $1.38B | · | · | · | $1.19B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.36B | · | · | · | $1.17B | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 30.1% | 17.8% | · | 27.4% | 29.4% | 19.5% | · | 31.7% | 30.1% | 23.9% | · | 33.0% | 32.2% | 29.9% | · | 41.7% | |
| Net Margin | 30.2% | 20.2% | · | 38.9% | 37.9% | 26.7% | · | 36.0% | 40.4% | 23.0% | · | 30.0% | 30.7% | 25.9% | · | 44.8% | |
| Pretax Margin | 35.6% | 23.1% | · | 47.0% | 41.3% | 29.9% | · | 40.1% | 45.9% | 22.3% | · | 33.0% | 34.3% | 27.1% | · | 51.4% | |
| EBITDA Margin | 30.1% | 21.2% | · | 27.4% | 29.4% | 23.7% | · | 31.7% | 30.1% | 27.5% | · | 33.0% | 32.2% | 33.1% | · | 41.7% | |
| ROA | 3.2% | 1.8% | · | 3.8% | 3.8% | 2.2% | · | 3.9% | 4.3% | 2.2% | · | 3.4% | 3.4% | 2.9% | · | 5.1% | |
| ROE | 4.2% | 2.4% | · | 4.8% | 4.8% | 2.9% | · | 4.9% | 5.5% | 2.9% | · | 4.3% | 4.3% | 3.8% | · | 6.8% | |
| ROIC | 3.3% | 1.7% | · | 2.6% | 3.1% | 1.7% | · | 3.4% | 3.1% | 2.7% | · | 3.8% | 3.5% | 3.5% | · | 4.5% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.6 | · | 4.1 | 4.6 | 4.9 | · | 5.3 | 5.4 | 5.3 | · | 5.2 | 5.5 | 5.5 | · | 5.4 | |
| Quick Ratio | 2.6 | 2.8 | · | 3.2 | 3.6 | 3.9 | · | 4.3 | 4.4 | 4.4 | · | 4.3 | 4.5 | 4.5 | · | 4.4 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 46.7 | · | 62.4 | 53.8 | 52.6 | · | 80.0 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 |
估值 (TTM) 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.33B | $14.06B | · | $14.18B | $13.97B | $13.44B | · | $13.78B | $13.21B | $12.83B | · | $12.62B | $12.11B | $11.92B | · | $12.21B | |
| Net Income TTM | $4.88B | $4.39B | · | $5.00B | $4.97B | $4.30B | · | $4.50B | $4.13B | $3.52B | · | $4.11B | $3.95B | $3.96B | · | $4.77B | |
| Market Cap | $86.05B | $106.55B | · | $76.58B | $71.50B | $86.32B | · | $142.23B | $141.68B | $129.17B | · | $108.71B | $94.56B | $107.97B | · | $88.86B | |
| Enterprise Value | $80.04B | $99.78B | · | $70.12B | $66.02B | $79.95B | · | $134.42B | $133.85B | $120.63B | · | $100.78B | $87.61B | $100.99B | · | $83.82B | |
| P/E | 13.7 | 19.1 | · | 12.4 | 11.9 | 16.9 | · | 26.9 | 29.1 | 31.2 | · | 22.7 | 20.6 | 23.5 | · | 16.4 | |
| P/S | 5.6 | 7.6 | · | 5.4 | 5.1 | 6.4 | · | 10.3 | 10.7 | 10.1 | · | 8.6 | 7.8 | 9.1 | · | 7.3 | |
| P/B | 2.7 | 3.4 | · | 2.5 | 2.4 | 2.9 | · | 4.9 | 5.0 | 4.8 | · | 4.4 | 3.9 | 4.6 | · | 4.1 | |
| P / Tangible Book | 2.8 | 3.5 | · | 2.6 | 2.5 | 3.1 | · | 5.0 | 5.2 | 5.0 | · | 4.6 | 4.1 | 4.8 | · | 4.3 | |
| P / Cash Flow | · | 98.8 | · | · | · | 82.6 | · | · | · | 85.4 | · | · | · | 78.9 | · | · | |
| P / FCF | · | 125.6 | · | · | · | 105.8 | · | · | · | 93.7 | · | · | · | 90.8 | · | · | |
| EV / EBITDA | 61.9 | 130.2 | · | 68.3 | 61.2 | 111.3 | · | 114.0 | 125.1 | 139.4 | · | 90.7 | 86.2 | 96.5 | · | 68.5 | |
| EV / FCF | · | 117.6 | · | · | · | 98.0 | · | · | · | 87.5 | · | · | · | 84.9 | · | · | |
| EV / Revenue | 5.2 | 7.1 | · | 4.9 | 4.7 | 5.9 | · | 9.8 | 10.1 | 9.4 | · | 8.0 | 7.2 | 8.5 | · | 6.9 | |
| Earnings Yield | 7.3% | 5.2% | · | 8.1% | 8.4% | 5.9% | · | 3.7% | 3.4% | 3.2% | · | 4.4% | 4.8% | 4.2% | · | 6.1% | |
| Payout Ratio | · | 13.5% | · | · | · | 11.6% | · | · | · | · | · | · | · | · | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B |
| 营业利润率 % | 24.9% | 28.1% | 30.9% | 38.9% | 55.7% |
| 净收入 | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B |
| 稀释后每股收益 (EPS) | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| 流动比率 | 4.1 | 4.7 | 5.7 | 5.1 | 3.6 |
| 速动比率 | 3.3 | 3.9 | 4.8 | 4.2 | 3.0 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $4.08B | $3.66B | $3.88B | $4.42B | $6.53B |
最新新闻 提及该公司的近期头条新闻
- FDG 的持仓暗示 20% 的潜在收益
- iShares MSCI USA Min Vol Factor ETF 经历巨额资金外流
- 再生元制药（REGN）宣布与Telix Pharmaceuticals Limited合作
- 盈利预览：展望再生元制药公司的报告
- Regeneron Pharma与Telix Pharma合作开发放射性药物疗法
- 吉姆·克莱默谈再生元（REGN）：“我认为该股在这里突破”
- Telix 与 Regeneron 合作推进下一代放射性药物疗法
- Formycon就FYB203在与Regeneron、Bayer达成和解后获得欧洲上市时间
- Regeneron Pharmaceuticals, Inc. (REGN) 是一只值得购买的好股票吗？
交易信号 近期买入/卖出信号，包含入场价和风险/回报比
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 1481 家申报者 · $34.8B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 124 (-38 与上一季度对比) | 163 (+66 与上一季度对比) | 484 (-68 与上一季度对比) | 526 (+42 与上一季度对比) | -166K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $4133919926 | 6629759 | 11.89% | 股份 |
| Dodge & Cox | $3037348765 | 4871137 | 8.73% | 股份 |
| STATE STREET CORP | $3014621356 | 4834688 | 8.67% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1979934668 | 3175313 | 5.69% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $1427303015 | 2297074 | 4.10% | 股份 |
| LOOMIS SAYLES & CO L P | $1014501372 | 1627003 | 2.92% | 股份 |
| PeakShares LLC | $975217000 | 1564 | 2.80% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $763126911 | 1223862 | 2.19% | 股份 |
| NORGES BANK | $731292700 | 1172808 | 2.10% | 股份 |
| Capital World Investors | $508138359 | 814925 | 1.46% | 股份 |
| TWO SIGMA ADVISERS, LP | $466626290 | 604540 | 1.34% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $432674406 | 693900 | 1.24% | 卖出期权 |
| TWO SIGMA INVESTMENTS, LP | $409119559 | 656124 | 1.18% | 股份 |
| GOLDMAN SACHS GROUP INC | $392576914 | 629594 | 1.13% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $351496357 | 563711 | 1.01% | 股份 |
| FIRST TRUST ADVISORS LP | $341158711 | 547132 | 0.98% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $299532285 | 480373 | 0.86% | 股份 |
| Robeco Institutional Asset Management B.V. | $287203770 | 460602 | 0.83% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $259935179 | 416870 | 0.75% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $249320598 | 399847 | 0.72% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $245478345 | 393685 | 0.71% | 股份 |
| National Pension Service | $236829845 | 379815 | 0.68% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $236259306 | 378900 | 0.68% | 买入期权 |
| ALLIANCEBERNSTEIN L.P. | $225872032 | 292338 | 0.65% | 股份 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $220714454 | 353970 | 0.63% | 股份 |
| BlackRock, Inc. | $207677479 | 333062 | 0.60% | 股份 |
| JANE STREET GROUP, LLC | $198659844 | 318600 | 0.57% | 买入期权 |
| Swiss National Bank | $182709691 | 293020 | 0.53% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $175962364 | 282199 | 0.51% | 股份 |
| BANK OF AMERICA CORP /DE/ | $171791505 | 275510 | 0.49% | 股份 |
| CITADEL ADVISORS LLC | $169166402 | 271300 | 0.49% | 买入期权 |
| FIL Ltd | $165543635 | 265490 | 0.48% | 股份 |
| CITADEL ADVISORS LLC | $164988684 | 264600 | 0.47% | 卖出期权 |
| FMR LLC | $162474852 | 260568 | 0.47% | 股份 |
| TD Asset Management Inc | $161694522 | 259317 | 0.46% | 股份 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $160530373 | 257450 | 0.46% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $159939881 | 256503 | 0.46% | 股份 |
| Nuveen, LLC | $158965911 | 254941 | 0.46% | 股份 |
| Caisse de depot et placement du Quebec | $156264112 | 250608 | 0.45% | 股份 |
| Assenagon Asset Management S.A. | $152721782 | 244927 | 0.44% | 股份 |
| Vanguard Global Advisers, LLC | $141371483 | 226724 | 0.41% | 股份 |
| California Public Employees Retirement System | $139840692 | 224269 | 0.40% | 股份 |
| Qube Research & Technologies Ltd | $138180829 | 221607 | 0.40% | 股份 |
| Legal & General Group Plc | $134385341 | 215520 | 0.39% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $130887905 | 209911 | 0.38% | 股份 |
| Squarepoint Ops LLC | $123814467 | 198567 | 0.36% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $123317506 | 197770 | 0.35% | 股份 |
| Candriam S.C.A. | $121893176 | 195674 | 0.35% | 股份 |
| MCDONALD CAPITAL INVESTORS INC/CA | $120366915 | 193038 | 0.35% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $119141861 | 154201 | 0.34% | 股份 |
| Swedbank AB | $118377821 | 189848 | 0.34% | 股份 |
| Carmignac Gestion | $113826706 | 182507 | 0.33% | 股份 |
| BANK OF NOVA SCOTIA | $113300959 | 181706 | 0.33% | 股份 |
| JANE STREET GROUP, LLC | $112548970 | 180500 | 0.32% | 卖出期权 |
| BARCLAYS PLC | $111306254 | 178507 | 0.32% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $109300950 | 175291 | 0.31% | 股份 |
| GOLDMAN SACHS GROUP INC | $106687694 | 171100 | 0.31% | 买入期权 |
| MILLENNIUM MANAGEMENT LLC | $102958925 | 165120 | 0.30% | 股份 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $102237489 | 163963 | 0.29% | 股份 |
| Bronte Capital Management Pty Ltd. | $101398828 | 162618 | 0.29% | 股份 |
| NORDEA INVESTMENT MANAGEMENT AB | $100247789 | 160258 | 0.29% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $99201835 | 159095 | 0.29% | 股份 |
| RHUMBLINE ADVISERS | $98390781 | 157794 | 0.28% | 股份 |
| Pictet Asset Management Holding SA | $96459212 | 153500 | 0.28% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $92422346 | 148222 | 0.27% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $92259602 | 147961 | 0.27% | 股份 |
| AMERIPRISE FINANCIAL INC | $90305429 | 144827 | 0.26% | 股份 |
| MACKENZIE FINANCIAL CORP | $84666132 | 135783 | 0.24% | 股份 |
| PRUDENTIAL FINANCIAL INC | $81380076 | 130513 | 0.23% | 股份 |
| Retirement Systems of Alabama | $79731436 | 127869 | 0.23% | 股份 |
| MARSHALL WACE, LLP | $79189580 | 127000 | 0.23% | 卖出期权 |
| Sound Shore Management Inc /CT/ | $79185839 | 126994 | 0.23% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $78779916 | 126343 | 0.23% | 股份 |
| ProShare Advisors LLC | $74350910 | 119240 | 0.21% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $69443026 | 111369 | 0.20% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $68488193 | 109838 | 0.20% | 股份 |
| Gotham Asset Management, LLC | $65574584 | 105165 | 0.19% | 股份 |
| Harvest Portfolios Group Inc. | $65232261 | 104616 | 0.19% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $62737149 | 100286 | 0.18% | 股份 |
| Mariner, LLC | $61632002 | 98826 | 0.18% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $61471693 | 98585 | 0.18% | 股份 |
| PARNASSUS INVESTMENTS, LLC | $59471998 | 95378 | 0.17% | 股份 |
| Davern Capital Partners, LP | $57764746 | 92640 | 0.17% | 股份 |
| AVIVA PLC | $57045180 | 91486 | 0.16% | 股份 |
| PFA Pension, Forsikringsaktieselskab | $56561245 | 90710 | 0.16% | 股份 |
| ARMISTICE CAPITAL, LLC | $55999504 | 89809 | 0.16% | 股份 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $54996852 | 88201 | 0.16% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $52429737 | 84084 | 0.15% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $52158497 | 83649 | 0.15% | 股份 |
| ROYAL BANK OF CANADA | $51450000 | 82513 | 0.15% | 股份 |
| CWM, LLC | $51303491 | 66400 | 0.15% | 股份 |
| PINNACLE ASSOCIATES LTD | $50660926 | 81247 | 0.15% | 股份 |
| GROUPAMA ASSET MANAGMENT | $49128285 | 77940 | 0.14% | 股份 |
| NEOS Investment Management LLC | $48213359 | 77322 | 0.14% | 股份 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $46765500 | 75000 | 0.13% | 股份 |
| Korea Investment CORP | $46737441 | 74955 | 0.13% | 股份 |
| Grantham, Mayo, Van Otterloo & Co. LLC | $46266668 | 74200 | 0.13% | 股份 |
| WOLVERINE TRADING, LLC | $45925425 | 81900 | 0.13% | 买入期权 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $45875500 | 59375 | 0.13% | 股份 |
| Woodline Partners LP | $45265886 | 72595 | 0.13% | 股份 |
公司内部人士 39 位内幕人士 · 3 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Leonard S Schleifer | Bd. Co-Chair, President & CEO | 2025年12月31日 M | 214523 | 0 | 0 | $0 |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2025年12月9日 F | 21673 | 0 | 0 | $0 |
| Christopher R. Fenimore | SVP Controller | 2021年8月20日 F | 19020 | 0 | 0 | $0 |
| Arthur F Ryan | 董事 | 2026年7月2日 S | 17303 | 0 | 48 | $-434683 |
| Anthony N Coles | 董事 | 2026年1月2日 A | 1714 | 0 | 0 | $0 |
| Christine A Poon | 董事 | 2026年1月2日 A | 5219 | 0 | 6 | $-4252745 |
| Michael S Brown | 董事 | 2026年1月2日 A | 1703 | 0 | 0 | $0 |
| David P Schenkein | 董事 | 2023年9月8日 A | 240 | 0 | 0 | $0 |
| Craig B. Thompson | 董事 | 2022年10月3日 A | 279 | 0 | 0 | $0 |
| REGENERON PHARMACEUTICALS, INC. | 10% 所有者 | 2021年2月17日 C | 2097314 | 0 | 0 | $0 |
| Sanofi | 10% 所有者 | 2020年6月9日 S | 279766 | 0 | 0 | $0 |
| Pharma Ag Novartis | 10% 所有者 | 2005年11月8日 S | — | 0 | 0 | $0 |
| Kathryn Guarini | — | 2026年8月10日 M | 603 | 0 | 1 | $-320000 |
| Huda Y Zoghbi | — | 2026年8月10日 M | 1703 | 0 | 1 | $-640000 |
| Joseph L Goldstein | — | 2026年1月2日 A | 6703 | 0 | 0 | $0 |
| George L Sing | — | 2026年1月2日 A | 31007 | 0 | 0 | $0 |
| George Yancopoulos | — | 2025年12月31日 M | 310460 | 0 | 0 | $0 |
| Joseph J Larosa | — | 2025年12月5日 A | 29517 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | — | 2021年12月9日 M | 2078 | 0 | 0 | $0 |
| Marion Mccourt | — | 2021年6月7日 M | 17038 | 0 | 0 | $0 |
| Andrew J Murphy | — | 2020年12月9日 A | 57350 | 0 | 0 | $0 |
| Robert E Landry | — | 2020年12月9日 A | 25903 | 0 | 0 | $0 |
| Neil Stahl | — | 2020年12月9日 A | 24715 | 0 | 0 | $0 |
| Bonnie L Bassler | — | 2020年6月19日 M | 643 | 0 | 0 | $0 |
| VAGELOS P ROY | — | 2019年12月16日 I | 2200 | 0 | 0 | $0 |
| Charles A Baker | — | 2018年1月2日 A | 9000 | 0 | 0 | $0 |
| Robert J Terifay | — | 2017年12月12日 A | 23293 | 0 | 0 | $0 |
| Michael S Aberman | — | 2016年12月16日 A | 16498 | 0 | 0 | $0 |
| Peter Powchik | — | 2016年12月16日 A | 2459 | 0 | 0 | $0 |
| Douglas S Mccorkle | — | 2015年12月29日 M | 6866 | 0 | 0 | $0 |
| Alfred G Gilman | — | 2015年8月6日 M | 8912 | 0 | 0 | $0 |
| Robert Alexander Ingram | — | 2015年5月22日 M | 1500 | 0 | 0 | $0 |
| Murray A Goldberg | — | 2014年12月16日 A | 64436 | 0 | 0 | $0 |
| Eric M Shooter | — | 2014年2月12日 M | 0 | 0 | 0 | $0 |
| William Roberts | — | 2013年9月18日 M | 13447 | 0 | 0 | $0 |
| Stuart Kolinski | — | 2010年6月3日 M | 16329 | 0 | 0 | $0 |
| Peter Dworkin | — | 2009年12月18日 A | — | 0 | 0 | $0 |
| Randall Rupp | — | 2007年4月13日 M | 3983 | 0 | 0 | $0 |
| Hans Peter Guler | — | 2004年10月8日 M | 10530 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC., SYMPHONY ACQUISITION SUB, INC. ×2 申报 | 2023年9月27日 | — | 初始申报 | — | SEC |
| Sanofi ×17 申报 | 2020年6月17日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 235 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| TBXU · Direxion Shares ETF Trust | 8.55% | 357 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 3.21% | 3840 NS | 2026年5月31日 | N-PORT |
| QQQA · ProShares Trust | 2.93% | 2168 NS | 2026年5月31日 | N-PORT |
| AGNG · Global X Funds | 2.48% | 3299 NS | 2026年5月31日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 2.19% | 344 NS | 2026年4月30日 | N-PORT |
| QQQG · Pacer Funds Trust | 2.18% | 348 NS | 2026年4月30日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 1.98% | 24491 NS | 2026年4月30日 | N-PORT |
| SGLC · RBB Fund, Inc. | 1.87% | 5922 NS | 2026年5月31日 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.78% | 1346 NS | 2026年4月30日 | N-PORT |
| HRTS · Tema ETF Trust | 1.67% | 1408 NS | 2026年5月31日 | N-PORT |
| BBP · ETFis Series Trust I | 1.52% | 1276 NS | 2026年4月30日 | N-PORT |
| RILA · Spinnaker ETF Series | 1.44% | 854 NS | 2026年4月30日 | N-PORT |
| COWG · Pacer Funds Trust | 1.40% | 43095 NS | 2026年4月30日 | N-PORT |
| FLAG · Global X Funds | 1.29% | 30 NS | 2026年4月30日 | N-PORT |
| NUGO · Nushares ETF Trust | 1.27% | 50872 NS | 2026年4月30日 | N-PORT |
| GMOV · GMO ETF Trust | 1.19% | 1758 NS | 2026年5月31日 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1.19% | 4569 NS | 2026年4月30日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1.18% | 47616 NS | 2026年4月30日 | N-PORT |
| COWZ · Pacer Funds Trust | 1.17% | 299615 NS | 2026年4月30日 | N-PORT |
| QQWZ · Pacer Funds Trust | 1.16% | 770 NS | 2026年4月30日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1.03% | 2010 NS | 2026年4月30日 | N-PORT |
| HEQQ · J.P. Morgan Exchange-Traded Fund ... | 0.99% | 444 NS | 2026年4月30日 | N-PORT |
| CVAR · ETF Opportunities Trust | 0.99% | 540 NS | 2026年4月30日 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0.90% | 1412 NS | 2026年5月31日 | N-PORT |
| RXL · ProShares Trust | 0.90% | 1051 NS | 2026年5月31日 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0.87% | 14942 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.85% | 6267 NS | 2026年4月30日 | N-PORT |
| SPXD · DBX ETF Trust | 0.79% | 87 NS | 2026年5月31日 | N-PORT |
| TAX · EA Series Trust | 0.78% | 324 NS | 2026年5月29日 | N-PORT |
| QIDX · Spinnaker ETF Series | 0.77% | 419 NS | 2026年4月30日 | N-PORT |
| JOET · Virtus ETF Trust II | 0.75% | 2512 NS | 2026年4月30日 | N-PORT |
| CANC · Tema ETF Trust | 0.75% | 2138 NS | 2026年5月31日 | N-PORT |
| FLRG · FIDELITY COVINGTON TRUST | 0.72% | 2871 NS | 2026年4月30日 | N-PORT |
| PEXL · Pacer Funds Trust | 0.69% | 448 NS | 2026年4月30日 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0.69% | 1360 NS | 2026年5月31日 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund ... | 0.63% | 771 NS | 2026年4月30日 | N-PORT |
| CGGO · Capital Group Global Growth Equit... | 0.57% | 105231 NS | 2026年5月31日 | N-PORT |
| LCOW · Pacer Funds Trust | 0.56% | 183 NS | 2026年4月30日 | N-PORT |
| FLCG · Federated Hermes ETF Trust | 0.51% | 4709 NS | 2026年5月31日 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0.50% | 8641 NS | 2026年4月30日 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund ... | 0.49% | 27715 NS | 2026年4月30日 | N-PORT |
| VLLU · Harbor ETF Trust | 0.47% | 29 NS | 2026年4月30日 | N-PORT |
| FTA · First Trust Exchange-Traded Alpha... | 0.46% | 8532 NS | 2026年4月30日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.46% | 77 NS | 2026年5月31日 | N-PORT |
| RDVI · First Trust Exchange-Traded Fund IV | 0.44% | 18975 NS | 2026年4月30日 | N-PORT |
| LRND · New York Life Investments ETF Trust | 0.43% | 1753 NS | 2026年4月30日 | N-PORT |
| WINN · Harbor ETF Trust | 0.42% | 6491 NS | 2026年4月30日 | N-PORT |
| KRMA · Global X Funds | 0.39% | 771 NS | 2026年5月31日 | N-PORT |
| QCLR · Global X Funds | 0.37% | 21 NS | 2026年4月30日 | N-PORT |
| QYLG · Global X Funds | 0.37% | 748 NS | 2026年4月30日 | N-PORT |